Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Serpin family B member 11 (SERPINB11) belongs to the broadly distributed serpin superfamily of proteins, which regulate proteolytic cascades relevant to processes such as inflammation, apoptosis, and development. Unlike other members, human SERPINB11 has evolved as a non-inhibitory serpin due to specific amino acid substitutions that disrupt the conformational fold needed for classic protease inhibition. While its canonical inhibitory activity is absent, SERPINB11 may have a role in adaptive responses to environmental pressures, especially host-pathogen interactions. Its expression and exact molecular function in human tissues remain incompletely characterized, though it is not currently regarded as a key mediator or therapeutic target in disease
Not applicable; SERPINB11’s lack of enzymatic inhibitory activity means it is not targeted by current drugs for a mechanism-based effect
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Serpin family B member 11 (SERPINB11).